166 related articles for article (PubMed ID: 6345633)
1. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Massie BM; Packer M; Hanlon JT; Combs DT
J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
[TBL] [Abstract][Full Text] [Related]
2. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
3. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
[TBL] [Abstract][Full Text] [Related]
4. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
5. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
7. Converting-enzyme inhibitor therapy for chronic heart failure.
Massie BM; Kramer BL; Topic N
Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
10. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
11. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
12. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
Daly P; Rouleau JL; Cousineau D; Burgess JH; Chatterjee K
Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
Packer M; Medina N; Yushak M; Meller J
Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
Kittleson MD; Johnson LE; Oliver NB
J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
18. Long-term control of congestive heart failure with captopril.
Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
[TBL] [Abstract][Full Text] [Related]
19. Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.
LeJemtel TH; Maskin CS; Mancini D; Sinoway L; Feld H; Chadwick B
Circulation; 1985 Aug; 72(2):364-9. PubMed ID: 3891133
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
Packer M; Medina N; Yushak M; Lee WH
Am Heart J; 1985 Jun; 109(6):1293-9. PubMed ID: 3890506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
